新天药业：控股股东质押521万股股份用于置换存量融资

Core Viewpoint - The announcement from Xintian Pharmaceutical indicates that its controlling shareholder, Xintian Zhiyao, has pledged 5.21 million shares, representing 7.38% of its holdings and 2.13% of the company's total share capital, with the purpose of replacing existing pledged financing [1] Group 1 - Xintian Zhiyao has notified that the pledged shares are set to mature on June 18, 2026, and the pledge is made to Zheshang Securities [1] - As of the announcement date, Xintian Zhiyao has cumulatively pledged 53.2468 million shares, which accounts for 75.43% of its holdings and 21.81% of the company's total share capital [1] - The current pledge does not involve any new financing and poses no risk of forced liquidation, thus having no impact on the company [1]